Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 15 years, with Q2 2025 value amounting to $15.2 million.

  • Lifecore Biomedical, Inc. \De\'s Receivables - Net fell 690.06% to $15.2 million in Q2 2025 from the same period last year, while for May 2025 it was $15.2 million, marking a year-over-year decrease of 690.06%. This contributed to the annual value of $15.2 million for FY2025, which is 5245.1% down from last year.
  • As of Q2 2025, Lifecore Biomedical, Inc. \De\'s Receivables - Net stood at $15.2 million, which was down 690.06% from $16.1 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Receivables - Net registered a high of $39.7 million during Q1 2022, and its lowest value of $15.2 million during Q2 2025.
  • Moreover, its 5-year median value for Receivables - Net was $27.5 million (2021), whereas its average is $26.1 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first plummeted by 5862.71% in 2021, then skyrocketed by 5862.35% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Receivables - Net (Quarter) stood at $27.5 million in 2021, then dropped by 0.13% to $27.5 million in 2022, then decreased by 29.23% to $19.4 million in 2023, then skyrocketed by 55.95% to $30.3 million in 2024, then plummeted by 50.0% to $15.2 million in 2025.
  • Its Receivables - Net was $15.2 million in Q2 2025, compared to $16.1 million in Q1 2025 and $30.3 million in Q4 2024.